GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » PensionAndRetirementBenefit

Noile-Immune Biotech (TSE:4893) PensionAndRetirementBenefit : 円0.0 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Noile-Immune Biotech PensionAndRetirementBenefit?

Noile-Immune Biotech's PensionAndRetirementBenefit for the quarter that ended in Mar. 2024 was 円0.0 Mil.

Noile-Immune Biotech's annual PensionAndRetirementBenefit stayed the same from Dec. 2021 (円5.2 Mil) to Dec. 2022 (円5.2 Mil) but then declined from Dec. 2022 (円5.2 Mil) to Dec. 2023 (円0.0 Mil).


Noile-Immune Biotech PensionAndRetirementBenefit Historical Data

The historical data trend for Noile-Immune Biotech's PensionAndRetirementBenefit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noile-Immune Biotech PensionAndRetirementBenefit Chart

Noile-Immune Biotech Annual Data
Trend Dec20 Dec21 Dec22 Dec23
PensionAndRetirementBenefit
5.23 5.23 5.23 -

Noile-Immune Biotech Quarterly Data
Dec20 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PensionAndRetirementBenefit Get a 7-Day Free Trial Premium Member Only - - - - -

Noile-Immune Biotech PensionAndRetirementBenefit Calculation

PensionAndRetirementBenefit is the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.


Noile-Immune Biotech (TSE:4893) Business Description

Traded in Other Exchanges
N/A
Address
2-12-10 Shiba-Daimon, Minato-ku, Tokyo, JPN, 105-0012
Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.

Noile-Immune Biotech (TSE:4893) Headlines

No Headlines